Cargando…
Personalizing age‐specific survival prediction and risk stratification in intracranial grade II/III ependymoma
BACKGROUND: Models for estimation of survival rates of patients with intracranial grade II/III ependymoma (EPN) are scarce. Considering the heterogeneity in prognostic factors between pediatric and adult patients, we aimed to develop age‐specific nomograms for predicting 3‐, 5‐, and 8‐year survival...
Autores principales: | Deng, Xiangyang, Zhang, Xiaojia, Yang, Liang, Lu, Xiangqi, Fang, Junhao, Yu, Lisheng, Li, Dandong, Sheng, Hansong, Yin, Bo, Zhang, Nu, Lin, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970043/ https://www.ncbi.nlm.nih.gov/pubmed/31793749 http://dx.doi.org/10.1002/cam4.2753 |
Ejemplares similares
-
The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched study
por: Deng, Xiangyang, et al.
Publicado: (2018) -
Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020) -
Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019) -
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019) -
Allicin Inhibits Proliferation by Decreasing IL-6 and IFN-β in HCMV-Infected Glioma Cells
por: Yang, Zelin, et al.
Publicado: (2020)